Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
06:27
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

51st ERA-EDTA CONGRESS

 

31 May - 3 June 2014 AMSTERDAM
FAQs
   
Discussion forum - 51st ERA-EDTA CONGRESS
    Topic - M) Dialysis. M6) Bone disease in dialysis patients.

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER.
 

Poster: 587
Visits: 102
Title: CINACALCET THERAPY IN DIALYSIS PATIENTS: RESULTS OF THE GERMAN REACT TRIAL
Authors: Helmut Reichel ,
Centre: Nephrological Center

You must be registered to reply or comment.

CINACALCET THERAPY IN DIALYSIS PATIENTS: RESULTS OF THE GERMAN REACT TRIAL

Helmut Reichel
Thread initiator
Subspeciality
Reg: 5/20/2014 6:38:00 PM
Comment# 1
I invite healthcare professionals to open debate around the issues raised in my poster, both those relating to research and to clinical practice.

Comment added on 5/20/2014 6:38:00 PM 
     

Hansjörg Rothe

Subspeciality Pharmacogenetics
Reg: 5/8/2012 12:28:00 AM
Comment# 2
It is interesting that the introduction of KDIGO recommendations didnt alter the cilical practice in this regard. This corresponds to the starting point of our poster (Sunday, 572: How to assess CKD-MBD in dialysis patients, a new look at on old parameter) in which we argue for a regionalization of therapy targets within the rather wide ranges of KDIGO guideline recommendations - an easy and inexpensive way to do this is the correlation of serum alkaline phosphatase levels with age: As we know, serum alkaline phosphatase is correlated with age in healthy adult populations (>2" years of age). If such a correlation with age is preserved in any given population of dialysis patients, this obviously means that CKD-MBD management in these patients is successful. On the other hand, if the correlation is lost, one can identify the outliers and remove them one by one until the correlation is established again: these outliers are the patients at risk in the population, they will need a closer look in terms of CKD-MBD management.

Comment added on 6/2/2014 10:11:00 AM 
     
You must be registered to reply or comment.



Most viewed poster for this congress
Poster: 7
Visits: 477
Title: SEVERE SYMPTOMATIC ACUTE HYPONATREMIA IN TRAUMATIC BRAIN INJURY RESPONDS VERY RAPIDLY SINGLE 15 MG DOSE OF TOLVAPTAN: A MAYO CLINIC HEALTH SYSTEM HOSPITAL EXPERIENCE - NEED FOR CAUTION WITH TOLVAPTAN IN YOUNGER PATIENTS WITH PRESERVED RENAL FUNCTION
Authors: MACAULAY ONUIGBO ,
Centre: MAYO CLINIC, ROCHESTER & MAYO CLINIC HEALTH SYSTEM, EAU CLAIRE

Poster most viewed in this topic
Poster: 587
Visits: 102
Title: CINACALCET THERAPY IN DIALYSIS PATIENTS: RESULTS OF THE GERMAN REACT TRIAL
Authors: Helmut Reichel ,
Centre: Nephrological Center


 








PosterSessionOnline
Logo Draft
 
Logo Cert